Table 1.
Demographic and histologic characteristics of HCC patients
| Characteristics | n = 131 |
|---|---|
| Age (yrs) | 55 (48–62) |
| Gender | |
| Female (%) | 24 (18.32%) |
| Male (%) | 107 (81.68%) |
| HBeAg | |
| Positive(%) | 26 (19.74%) |
| Negative(%) | 77 (58.77%) |
| Not available(%) | 28 (21.37%) |
| Serum HBsAga (IU/mL) | |
| <250 | 35 (33.98%) |
| >250 | 68 (66.02%) |
| Serum HBV DNAb (IU/mL) | |
| <500 | 78 (68.42%) |
| >500 | 36 (31.58%) |
| Diagnostic markers | |
| Ki-67 | 131 (100%) |
| Hep-par1 | 127 (96.95%) |
| GPC-3 | 128 (97.71%) |
| GSc | 125 (96.15%) |
| HSP70d | 124 (96.88%) |
| α-fetoprotein (ng/ml) | 39.9 (8.0–522.2) |
| Alanine transferase ALT (U/L) | 31.0 (21.0–49.3) |
| Necro-Inflammation (G1,G2,G3,NA) | 17:66:30:18 |
| Fibrosis (S1,S2,S3,S4,NA) | 5:6:4:98:18 |
| Tumor Differentiation (1,2,3) | 12:98:21 |
| MVI (M0,M1,M2) | 60: 44: 27 |
| Satellite nodule | 7 (5.34%) |
| Nodule in nodule | 27 (20.61%) |
| Recurrence | |
| Yes | 68 (51.90%) |
| No | 61 (46.56%) |
| death | 2 (1.52%) |
Data expressed as the median (interquartile range)
a. 28 cases missing serum HBsAg information;
b. 17 cases missing serum HBV DNA information;
c. 1 cases missing IHC GS information;
d. 3 case missing IHC Hsp70 information;